Amorphous oxide - A platform for drug delivery

Journal of Controlled Release

Volumn 102, Issue 3, 2005, Pages 539-549

  Shih, Chun Ming ^a   Lin, Shing Jong ^b,c   Su, Yea Yang ^b   Shih, Chun Che ^b,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Amorphous oxide; Drug loading; Heparin; Stainless steel

Indexed keywords

AMORPHOUS FILMS; CARDIOVASCULAR SYSTEM; CHEMICAL ANALYSIS; CYCLIC VOLTAMMETRY; ELECTRON SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PLASTIC COATINGS; POLYMERS;

ACTIVATED CLOTTING TIME (ACT); DRUG DELIVERY; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY (EIS); ELECTRON SPECTROSCOPY FOR CHEMICAL ANALYSIS (ESCA); METALLIC CORROSION;

DRUG PRODUCTS;

HEPARIN; OXIDE; POLYMER; STAINLESS STEEL;

ARTICLE; BLOOD CLOTTING TIME; CARDIOVASCULAR SYSTEM; CHEMICAL ANALYSIS; CYCLIC POTENTIOMETRY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; ELECTROCHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; SPECTROSCOPY; STENT;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; ELECTROCHEMISTRY; HEPARIN; OXIDES; SPECTRUM ANALYSIS; WHOLE BLOOD COAGULATION TIME;

EID: 12844249483     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2004.10.031     Document Type: Article

References (60)

1. M. Oberhoff, C. Herdeg, A. Baumbach, and K.R. Karsch Stent-based antirestenotic coatings (sirolimus/paclitaxel) Catheter. Cardiovasc. Interv. 55 2002 404 408
2. D.E. Kandzari, J. Kay, J.C. O'Shea, B.H. Trichon, M. Donahue, L. Liao, and S.V. Rao Highlights from the American Heart Association annual scientific sessions 2001: November 11 to 14, 2001 Am. Heart J. 143 2002 217 228
3. M. Sturek, and H.K. Reddy New tools for prevention of restenosis could decrease the "oculo-stento" reflex Cardiovasc. Res. 53 2002 292 293
4. E. Regar, G. Sianos, and P.W. Serruys Stent development and local drug delivery Br. Med. Bull. 59 2001 227 248
5. R. Fox American Heart Association 2001 scientific sessions: late-breaking science-drug-eluting stents Circulation 104 2001 E9052
6. M.K. Hong, R. Kornowski, O. Bramwell, A.O. Ragheb, and M.B. Leon Paclitaxel-coated Gianturco-Roubin II (GR II) stents reduce neointimal hyperplasia in a porcine coronary in-stent restenosis model Coron. Artery Dis. 12 2001 513 515
7. F. Liistro, and A. Colombo Late acute thrombosis after paclitaxel eluting stent implantation Heart 86 2001 262 264
8. C.W. Hwang, D. Wu, and E.R. Edelman Physiological transport forces govern drug distribution for stent-based delivery Circulation 104 2001 600 605
9. A. Farb, P.F. Heller, S. Shroff, L. Cheng, F.D. Kolodgie, A.J. Carter, D.S. Scott, J. Froehlich, and R. Virmani Pathological analysis of local delivery of paclitaxel via a polymer-coated stent Circulation 104 2001 473 479
10. N. Kipshidze, J.W. Moses, and M.B. Leon Paclitaxel-coated stent: is there a light at the end of the tunnel? J. Am. Coll. Cardiol. 38 2001 292 293
11. A.W. Heldman, L. Cheng, G.M. Jenkins, P.F. Heller, D.W. Kim, M. Ware, C. Nater Jr., R.H. Hruban, B. Rezai, B.S. Abella, K.E. Bunge, J.L. Kinsella, S.J. Sollott, E.G. Lakatta, J.A. Brinker, W.L. Hunter, and J.P. Froehlich Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis Circulation 103 2001 2289 2295
12. D.E. Drachman, E.R. Edelman, P. Seifert, A.R. Groothuis, D.A. Bornstein, K.R. Kamath, M. Palasis, D. Yang, S.H. Nott, and C. Rogers Neointimal thickening after stent delivery of paclitaxel: change in composition and arrest of growth over six months J. Am. Coll. Cardiol. 36 2000 2325 2332
13. C. Herdeg, M. Oberhoff, D.I. Siegel-Axel, A. Baumbach, A. Blattner, A. Kuttner, S. Schroder, and K.R. Karsch Paclitaxel: a chemotherapeutic agent for prevention of restenosis? Experimental studies in vitro and in vivo Z. Kardiol. 89 2000 390 397
14. C. Herdeg, M. Oberhoff, and K.R. Karsch Antiproliferative stent coatings: taxol and related compounds Semin. Interv. Cardiol. 3 1998 197 199
15. A. Baumbach, C. Herdeg, M. Kluge, M. Oberhoff, M. Lerch, K.K. Haase, C. Wolter, S. Schroder, and K.R. Karsch Local drug delivery: impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall Catheter. Cardiovasc. Interv. 47 1999 102 106
16. M. Poon, J.J. Badimon, and V. Fuster Overcoming restenosis with sirolimus: from alphabet soup to clinical reality Lancet 359 2002 619 622
17. P.R. Marshall Preparing for the introduction of new technologies: who is going to pay for them? J. Cardiovasc. Manag. 13 2002 14 20
18. H.C. Lowe, and L.M. Khachigian Coating stents with antirestenotic drugs: the blunderbuss or the magic bullet? Circulation 105 2002 E29
19. B.J. Rensing, J. Vos, P.C. Smits, D.P. Foley, M.J. van den Brand, W.J. van der Giessen, P.J. de Feijter, and P.W. Serruys Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up Eur. Heart J. 22 2001 2125 2130
20. R. Beyar, and A. Roguin The sirolimus coated stent: will the Achilles heel of interventional cardiology finally be cured? Eur. Heart J. 22 2001 2054 2057
21. J.E. Sousa, M.A. Costa, A.C. Abizaid, B.J. Rensing, A.S. Abizaid, L.F. Tanajura, K. Kozuma, G. Van Langenhove, A.G. Sousa, R. Falotico, J. Jaeger, J.J. Popma, and P.W. Serruys Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up Circulation 104 2001 2007 2011
22. P.S. Teirstein Living the dream of no restenosis Circulation 104 2001 1996 1998
23. T. Suzuki, G. Kopia, S. Hayashi, L.R. Bailey, G. Llanos, R. Wilensky, B.D. Klugherz, G. Papandreou, P. Narayan, M.B. Leon, A.C. Yeung, F. Tio, P.S. Tsao, R. Falotico, and A.J. Carter Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model Circulation 104 2001 1188 1193
24. S.O. Marx, and A.R. Marks Bench to bedside: the development of rapamycin and its application to stent restenosis Circulation 104 2001 852 855
25. P.R. Hansen, U. Abildgaard, A.M. Galloe, and E. Kassis Prevention of instant restenosis after coronary angioplasty by implantation of rapamycin-coated stents Ugeskr. Læger. 163 2001 1714
26. D. Zohlnhofer, C.A. Klein, T. Richter, R. Brandl, A. Murr, T. Nuhrenberg, A. Schomig, P.A. Baeuerle, and F.J. Neumann Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-binding protein 12 unregulation Circulation 103 2001 1396 1402
27. J.E. Sousa, M.A. Costa, A. Abizaid, A.S. Abizaid, F. Feres, I.M. Pinto, A.C. Seixas, R. Staico, L.A. Mattos, A.G. Sousa, R. Falotico, J. Jaeger, J.J. Popma, and P.W. Serruys Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study Circulation 103 2001 192 195
28. A. Abizaid, G. Dangas, M. Costa, A. Abizaid, A. Sousa, P.W. Serruys, and E. Sousa Sirolimus-coated stent prevents neointimal proliferation Curr. Interv. Cardiol. Rep. 3 2001 1 4
29. U. Sigwart, S. Prasad, P. Radke, and I. Nadra Stent coatings J. Invasive Cardiol. 13 2001 141 142
30. A.R. Marks Attacking heart disease with novel molecular tools Bull. N. Y. Acad Med. 73 1996 25 36
31. W.J. Der Giessen, H.M. van Beusekom, R. Larsson, and P. Serruys Heparin-coated coronary stents Curr. Interv. Cardiol. Rep. 1 1999 234 240
32. M.C. Vrolix, V.M. Legrand, J.H. Reiber, G. Grollier, M.J. Schalij, P. Brunel, L. Martinez-Elbal, M. Gomez-Recio, F.W. Bar, M.E. Bertrand, A. Colombo, and J. Brachman Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators Am. J. Cardiol. 86 2000 385 389
33. J.F. Kocsis, G. Llanos, and E. Holmer Heparin-coated stents J. Long-Term Eff. Med. Implants 10 2000 19 45
34. R. Blezer, L. Cahalan, P.T. Cahalan, and T. Lindhout Heparin coating of tantalum coronary stents reduces surface thrombin generation but not factor IXa generation Blood Coagul. Fibrinolysis 9 1998 435 440
35. H. Emanuelsson, W.J. van der Giessen, and P.W. Serruys Benestent II: back to the future J. Interv. Cardiol. 7 1994 587 592
36. C. Rogers, and E.R. Edelman Endovascular stent design dictates experimental restenosis and thrombosis Circulation 91 1995 2995 3001
37. T.A. Fischell Polymer coatings for stents. Can we judge a stent by its cover? Circulation 94 1996 1494 1495
38. W.J. van der Giessen, A.M. Lincoff, R.S. Schwartz, H.M.M. van Beusekom, P.W. Serruys, D.R. Holmes, S.G. Ellis, and E.J. Topol Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 94 1996 1690 1697
39. B.D. Ratner Surface modification of polymers for biomedical applications: chemical, biological, and surface analytical challenges B.D. Ratner D.G. Castner Surface Modification of Polymeric Biomaterials 1997 Plenum Press New York 1 9
40. B.D. Ratner, and A.S. Hoffman Thin films, grafts, and coatings B.D. Ratner A.S. Hoffman F.J. Schoen J.E. Lemons Biomaterials Science: An Introduction to Materials in Medicine 1996 Academic Press San Diego 105 118
41. A.S. Hoffman Immobilization of biomolecules and cells on and within polymeric biomaterials Clin. Mater. 11 1992 61 66
42. P. Cuatrecasas, and C.B. Annsen Affinity chromatography Annu. Rev. Biochem. 40 1971 259
43. C.C. Shih, C.M. Shih, Y.Y. Su, L.H.J. Su, M.S. Chang, and S.J. Lin Effect of surface oxide properties on corrosion resistance of 316LVM stainless steel for biomedical applications Corros. Sci. 46 2004 427 441
44. C.C. Shih, S.J. Lin, K.H. Chung, Y.L. Chen, and Y.Y. Su Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide J. Biomed. Mater. Res. 52 2000 323 332
45. C.C. Shih, C.M. Shih, Y.Y. Su, M.S. Chang, and S.J. Lin Characterization of the thrombogenic potential of surface oxides on stainless steel for implant purposes Appl. Surf. Sci. 219 2003 347 362
46. C.C. Shih, C.M. Shih, Y.Y. Su, and S.J. Lin Impact on the thrombogenicity of surface oxide properties of 316LVM stainless steel for biomedical applications J. Biomed. Mater. Res. 67A 2003 1320 1328
47. C.C. Shih, C.M. Shih, Y.L. Chen, Y.Y. Su, J.S. Shih, C.F. Kwok, and S.J. Lin Growth inhibition of cultured smooth muscle cells by corrosion products of 316LVM stainless steel wire J. Biomed. Mater. Res. 57 2001 200 207
48. C.C. Shih, C.M. Shih, Y.Y. Su, L.H.J. Su, M.S. Chang, and S.J. Lin Quantitative evaluation of thrombosis by electrochhemical methodology Thromb. Res. 111 2003 103 109
49. C.C. Shih, C.M. Shih, Y.Y. Su, S.J. Lin, Amorphous oxide on stainless Steel for Cardiovascular Applications" Paper presented at 7th World Biomaterials Conference, Sydney, Australia, May, 2004.
50. L. Yuan Advances in experimental medicine and biology R.A. Bradshaw S. Wessler Heparin: Structure, Function and Clinical Implications, Three-Dimensional Model of Heparin vol. 82 1975 Plenum Press New York 39 49
51. M. Hrincovini, M. Guerrini, A. Bisio, G. Torri, M. Petition, and B. Casy Conformation of heparin pentasaccharide bound to antithrombin III J. Biochem. 359 2001 265 272
52. B. Mulloy, M.J. Jones, and D.B. Davies NMR and molecular-modeling studies of the solution conformation of heparin J. Biochem. 293 1993 849 858
53. S.W. Kim, and J. Feljen Surface modification of polymers for improved blood compatibility D. Williams CRC Critical Reviews in Biocompatibility vol. 1 (3) 1985 229 260
54. C.C. Shih, C.M. Shih, Y.Y. Su, S.J. Lin, Loading mechanism of drugs on polymer-free oxide films of metallic cardiovascular implants. Submitted to Biomaterials.
55. N. Larsson, P. Stenius, J.C. Eriksson, R. Maripuu, and B. Lindberg ESCA studied of sulfated polyethylene surfaces modified by adsorption of polyethleneimine and colloidal silica particles J. Colloid Interface Sci. 90 1982 127 136
56. I. Epelboin, M. Keddam, and J.C. Lestrade Faradaic impedance and intermediates in electrochemical reactions Discuss. Faraday Soc. 56 1973 264 275
57. C.E. Conway A profile of electrode kinetics over the past twenty-five years J. Electrochem. Soc. 124 1977 410C 421C
58. I. Epelboin, and M. Keddam Faradaic impedances: diffusion impedance and reaction impedance J. Electrochem. Soc. 117 1970 1052 1056
59. H.I. Flom-Halvorsen, E. Ovrum, M. Abdelnoor, S. Bjornsen, and F. Brosstad Assessment of heparin anticoagulation: comparsion of two commercially available methods Ann. Thorac. Surg. 67 1999 1012 1017
60. J.D. Marmur, S.X. Anand, R.S. Bagga, J. Fareed, C.M. Pan, S.K. Sharma, and M.F. Richard The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration JACC 41 2003 394 402